Mark Yen-Ping Kuo

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Yi-Jie Lu, Yi-Ting Deng, Hui-Hsin Ko, Hsin-Hui Peng, Hsiang-Chieh Lee, Mark Yen-Ping Kuo, Shih-Jung Cheng
Lysyl oxidase-like 2 promotes stemness and enhances antitumor effects of gefitinib in head and neck cancer via IFIT1 and IFIT3. Cancer science (2023)
Hui-Hsin Ko, Hsin-Hui Peng, An Ning Cheng, Han-Yi Elizabeth Chou, Hsin-Han Hou, Wei-Ting Kuo, Wei-Wen Liu, Mark Yen-Ping Kuo, Alan Yueh-Luen Lee, Shih-Jung Cheng
Metastasis and immunosuppression promoted by mtDNA and PD-L1 in extracellular vesicles are reversed by WGP β-glucan in oral squamous cell carcinoma. Cancer science (2023)
Hsin-Hui Peng, Hui-Hsin Ko, Nai-Chi Chi, Yi-Ping Wang, Hsiang-Chieh Lee, Pei-Yao Pan, Mark Yen-Ping Kuo, Shih-Jung Cheng
Upregulated NPM1 is an independent biomarker to predict progression and prognosis of oral squamous cell carcinomas in Taiwan. Head & neck 42 (1) (2019)
Hui-Hsin Ko, Hsin-Hui Peng, Shih-Jung Cheng, Mark Yen-Ping Kuo
Increased salivary AKR1B10 level: Association with progression and poor prognosis of oral squamous cell carcinoma. Head & neck 40 (12) (2018)